How Big Is the Dengue Drug Market | Growth Analysis & Segmentation 2031

Q: What is the market size of the dengue drug market in 2025 and 2031?

The dengue drug market was valued at USD 1.05 billion in 2024 and is anticipated to exceed USD 2.1 billion by 2031,

Q: What is the CAGR of the dengue drug market between 2025 and 2031?

The dengue drug market is anticipated to grow at a CAGR of 12.6% during the forecast period.

Q: What are the key trends in the dengue drug market?

Key trends include repurposing of antiviral drugs, increased collaboration between pharmaceutical firms, and development of RNA-based and broad-spectrum therapies.

Q: What are the main drivers of the dengue drug market?

The dengue drug market is driven by rising dengue cases, strong R&D investment, regulatory support, and improving healthcare infrastructure in endemic regions.

Q: How does 6W market outlook report help businesses in making decisions?

6W monitors the market across 60+ countries Globally, publishing an annual market outlook report that analyses trends, key drivers, Size, Volume, Revenue, opportunities, and market segments. This report offers comprehensive insights, helping businesses understand market dynamics and make informed decisions.

Q: Do you also provide customisation in the market study?

Yes, we provide customisation as per your requirements. To learn more, feel free to contact us on sales@6wresearch.com

Code: MTA5970

Publication Date: Jul 2025

What is the Dengue drug Market Size?

According to 6Wresearch internal database and industry insights, the Dengue drug market was valued at USD 1.05 billion in 2024 and is anticipated to exceed USD 2.1 billion by 2031, registering a steady at a CAGR of 12.6% during the forecast period.

This market is witnessing strong growth due to increasing global prevalence of dengue infections, rising investments in antiviral research, and a growing pipeline of targeted therapies. The demand is further accelerated by public health initiatives in endemic regions, awareness campaigns, and support for fast-track approvals. Technological advancements in drug discovery, coupled with the development of supportive care and vaccine-adjacent therapies, are also fostering market growth.

Major Growth Factors of the Dengue drug Market

Rising incidence of dengue fever globally
Growing focus on vector-borne disease control
Increasing R&D investment in antiviral drugs
Public and private sector support for drug development
Rising awareness about early diagnosis and treatment
Expanding healthcare access in developing countries
Fast-track approvals by regulatory authorities
Integration of AI and biotechnology in drug discovery

Dengue drug Market Trends

The dengue drug market is anticipated to witness a surge in trend of development of antiviral molecules aimed at both prevention and treatment of dengue. Companies are increasingly focused on repurposing existing antivirals and creating formulations that offer better efficacy and fewer side effects. The rise in collaborative efforts between pharma companies and global health organizations is also influencing the trend toward scalable and affordable drug solutions.

Emerging Developments in the Dengue drug Market

The dengue drug market is undergoing significant innovation with the emergence of targeted antiviral therapies, including RNA-based drug candidates. Biopharmaceutical firms are emphasizing the creation of broad-spectrum antivirals and combination therapies. Advancements in clinical trial methodologies and real-time disease surveillance are also playing a key role in the acceleration of drug development pipelines.